Nitto BioPharma Inc.
June 16, 2025
Company Presentation
Platform for Therapeutics
NBPI is a unique and differentiated biopharmaceutical company that operates at the forefront of nucleic acid drug delivery technologies. In driving Nitto’s corporate vision of Innovation for Customers, Nitto BioPharma develops and leverages its innovative drug delivery technologies (DDS platform) to establish collaborative relationships to develop and enable novel cutting edge genetic medicines to benefit patients and the community.
Company HQ City:
San Diego
Company HQ State:
CA
Company HQ Country:
United States
Year Founded:
2014
Lead Product in Development:
In vivo CAR-T Asset
CEO
Takeshi Mitsuhara, President
Development Phase of Lead Product
Pre-Clinical
Number of Unlicensed Products Looking for Licensing
Three (3)
Exchange
OTCMKTS
Ticker
NDEKY
When you expect your next catalyst update?
March 2026
What is your next catalyst (value inflection) update?
March 2026
Primary Speaker
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}